4th Nov 2011 11:45
RNS Number : 5266R
AGI Therapeutics plc
04 November 2011
AGI Therapeutics plc ('AGI')
Holding in Company
AGI was notified on 2nd November 2011 that Paul Johnson has increased his shareholding to 2,050,615 shares representing 3.04% of AGI's Issued share capital.
Contact Information
AGI Therapeutics
David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Potentially Ai